Lonsurf 20 MG-8.19 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ4Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,088
Award facts
- Contract value 100% obligated
- $22,087.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,087.68 to AmerisourceBergen Drug Corp for the supply of LONSURF (20 mg-8.19 mg tablets, quantity 60) with a completion date of February 4, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The awarded contract is a child delivery order issued under AmerisourceBergen's parent organization, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order represents routine pharmaceutical procurement under DLA's broader medical supply chain operations. LONSURF is a brand-name oncology medication used in cancer treatment, reflecting the DLA's continued need to supply specialty pharmaceuticals to military treatment facilities and other federal healthcare systems worldwide. AmerisourceBergen's extensive federal contracting history demonstrates its capability to efficiently fulfill government requirements for a diverse range of pharmaceutical products across multiple therapeutic domains. The firm fixed-price structure and delivery order format provide the DLA with cost certainty and expedited procurement under the established IDC vehicle, supporting the agency's mission to maintain critical pharmaceutical inventory for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FCZ4Y?
SPE2DR26FCZ4Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ4Y worth?
The government has obligated $22,088 on SPE2DR26FCZ4Y.
Is contract SPE2DR26FCZ4Y an order under another contract?
Yes. SPE2DR26FCZ4Y is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ4Y competed?
The extent of competition for SPE2DR26FCZ4Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award